These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 15840500)

  • 1. A reversed-phase high-performance liquid chromatography method for analysis of monoclonal antibody-maytansinoid immunoconjugates.
    Fleming MS; Zhang W; Lambert JM; Amphlett G
    Anal Biochem; 2005 May; 340(2):272-8. PubMed ID: 15840500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the composition of immunoconjugates using size-exclusion chromatography coupled to mass spectrometry.
    Lazar AC; Wang L; Blättler WA; Amphlett G; Lambert JM; Zhang W
    Rapid Commun Mass Spectrom; 2005; 19(13):1806-14. PubMed ID: 15945030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor delivery and in vivo processing of disulfide-linked and thioether-linked antibody-maytansinoid conjugates.
    Erickson HK; Widdison WC; Mayo MF; Whiteman K; Audette C; Wilhelm SD; Singh R
    Bioconjug Chem; 2010 Jan; 21(1):84-92. PubMed ID: 19891424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of antibody-maytansinoid conjugates allows for efficient detoxification via liver metabolism.
    Sun X; Widdison W; Mayo M; Wilhelm S; Leece B; Chari R; Singh R; Erickson H
    Bioconjug Chem; 2011 Apr; 22(4):728-35. PubMed ID: 21391620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PK assays for antibody-drug conjugates: case study with ado-trastuzumab emtansine.
    Dere R; Yi JH; Lei C; Saad OM; Huang C; Li Y; Baudys J; Kaur S
    Bioanalysis; 2013 May; 5(9):1025-40. PubMed ID: 23641694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-CD22-MCC-DM1 and MC-MMAF conjugates: impact of assay format on pharmacokinetic parameters determination.
    Stephan JP; Chan P; Lee C; Nelson C; Elliott JM; Bechtel C; Raab H; Xie D; Akutagawa J; Baudys J; Saad O; Prabhu S; Wong WL; Vandlen R; Jacobson F; Ebens A
    Bioconjug Chem; 2008 Aug; 19(8):1673-83. PubMed ID: 18637680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural characterization of the maytansinoid-monoclonal antibody immunoconjugate, huN901-DM1, by mass spectrometry.
    Wang L; Amphlett G; Blättler WA; Lambert JM; Zhang W
    Protein Sci; 2005 Sep; 14(9):2436-46. PubMed ID: 16081651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro characterization of the drug-drug interaction potential of catabolites of antibody-maytansinoid conjugates.
    Davis JA; Rock DA; Wienkers LC; Pearson JT
    Drug Metab Dispos; 2012 Oct; 40(10):1927-34. PubMed ID: 22752008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of tryptophan oxidation of monoclonal antibody by reversed phase high performance liquid chromatography.
    Yang J; Wang S; Liu J; Raghani A
    J Chromatogr A; 2007 Jul; 1156(1-2):174-82. PubMed ID: 17379231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural Characterization of a Monoclonal Antibody-Maytansinoid Immunoconjugate.
    Luo Q; Chung HH; Borths C; Janson M; Wen J; Joubert MK; Wypych J
    Anal Chem; 2016 Jan; 88(1):695-702. PubMed ID: 26629796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maytansinoid-BODIPY Conjugates: Application to Microscale Determination of Drug Extinction Coefficients and for Quantification of Maytansinoid Analytes.
    Fishkin N
    Mol Pharm; 2015 Jun; 12(6):1745-51. PubMed ID: 25738231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of a reversed-phase high-performance liquid chromatography/mass spectrometry method for characterizing recombinant antibody heterogeneity and stability.
    Dillon TM; Bondarenko PV; Rehder DS; Pipes GD; Kleemann GR; Ricci MS
    J Chromatogr A; 2006 Jul; 1120(1-2):112-20. PubMed ID: 16448656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and quantification of phenolic compounds in grapes by HPLC-PDA-ESI-MS on a semimicro separation scale.
    Nicoletti I; Bello C; De Rossi A; Corradini D
    J Agric Food Chem; 2008 Oct; 56(19):8801-8. PubMed ID: 18781764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trace level detection and quantitation of ethyl diazoacetate by reversed-phase high performance liquid chromatography and UV detection.
    Axe BP
    J Pharm Biomed Anal; 2006 Jun; 41(3):804-10. PubMed ID: 16495031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LC-MS/MS method for the simultaneous determination of Lys-MCC-DM1, MCC-DM1 and DM1 as potential intracellular catabolites of the antibody-drug conjugate trastuzumab emtansine (T-DM1).
    Liu Y; Zhou F; Sang H; Ye H; Chen Q; Yao L; Ni P; Wang G; Zhang J
    J Pharm Biomed Anal; 2017 Apr; 137():170-177. PubMed ID: 28131055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of synthetic conditions on the stability of methotrexate-monoclonal antibody conjugates determined by reversed phase high performance liquid chromatography.
    Hudecz F; Garnett MC; Khan T; Baldwin RW
    Biomed Chromatogr; 1992; 6(3):128-32. PubMed ID: 1525486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Site-specific trastuzumab maytansinoid antibody-drug conjugates with improved therapeutic activity through linker and antibody engineering.
    Pillow TH; Tien J; Parsons-Reponte KL; Bhakta S; Li H; Staben LR; Li G; Chuh J; Fourie-O'Donohue A; Darwish M; Yip V; Liu L; Leipold DD; Su D; Wu E; Spencer SD; Shen BQ; Xu K; Kozak KR; Raab H; Vandlen R; Lewis Phillips GD; Scheller RH; Polakis P; Sliwkowski MX; Flygare JA; Junutula JR
    J Med Chem; 2014 Oct; 57(19):7890-9. PubMed ID: 25191794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct determination of residual Pluronic F-68 in in-process samples from monoclonal antibody preparations by high performance liquid chromatography.
    Chung HH; Zhou C; Khor HK; Qiu J
    J Chromatogr A; 2011 Apr; 1218(15):2106-13. PubMed ID: 21227430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statistics of the distribution of the abundance of molecules with various drug loads in maytansinoid antibody-drug conjugates.
    Goldmacher VS; Amphlett G; Wang L; Lazar AC
    Mol Pharm; 2015 Jun; 12(6):1738-44. PubMed ID: 25635630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding How the Stability of the Thiol-Maleimide Linkage Impacts the Pharmacokinetics of Lysine-Linked Antibody-Maytansinoid Conjugates.
    Ponte JF; Sun X; Yoder NC; Fishkin N; Laleau R; Coccia J; Lanieri L; Bogalhas M; Wang L; Wilhelm S; Widdison W; Pinkas J; Keating TA; Chari R; Erickson HK; Lambert JM
    Bioconjug Chem; 2016 Jul; 27(7):1588-98. PubMed ID: 27174129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.